Because of the holidays and the hustle and bustle around JP Morgan, we’re wrapping up our hires roundups from December and January into three double issues – stay tuned for other roundups f
The use of artificial intelligence (AI) in the biopharma industry has the potential to revolutionise drug discovery and development, as well as improve patient care.
Inato has raised $20 million in early-stage financing to support the continued development of its clinical trial platform, which connect sponsors with its network of thous